The following trials are fully managed:
Title: Randomised, Phase II open label study of Rituximab/Ibritinib vs Rituximab/Chemo in older patients with mantle cell lymphoma.
Chief Investigator: Professor Simon Rule, Plymouth Hospitals NHS Trust
Title: Novel use of TXA to reduce the need for nasal packing in epistaxis.
Chief Investigator: Dr Adam Reuben, Royal Devon and Exeter NHS Foundation Trust
Title: Simvastatin as a neuroprotective treatment for Parkinson’s disease – a double-blind, placebo controlled clinical learning study in patients of moderate severity.
Chief Investigator: Dr Camille Carroll, Faculty of Medicine and Dentistry, University of Plymouth.
Title: A pilot multi-centre three arm randomised controlled feasibility study (for a definitive trial) of the clinical and cost-effectiveness of facet joint injections in patients with persistent non-specific low back pain of more than six months' duration.
Chief Investigator: Professor Richard Langford, Bath and The London NHS Trust
This unit receives National Institute for Health Research CTU Support Funding. This funding has been awarded to support the unit in developing and supporting NIHR trials.